Power Wind Health Industry Incorporated AI Stock Analysis
Power Wind Health Industry Incorporated (8462) AI Stock Analysis
Power Wind Health Industry Incorporated
(TWSE:8462)
Power Wind Health scores above average, driven by robust cash generation and a sharp recovery in revenue and margins since 2021, supported by an inexpensive 14.3x P/E and a near 5% dividend yield. The main risk is financial structure: debt of NT$7.52 billion versus NT$2.36 billion of equity leaves the company sensitive to interest costs and any slowdown in membership demand, even though leverage is improving. Near-term technicals are soft, with the share price below its 20-, 50- and 100-day moving averages and negative MACD momentum, although oversold readings and support above the 200-day average temper the downside signal.
Power Wind Health Industry Incorporated (8462) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 11.74B
- Dividend Yield
- 4.84%
- Average Volume (3M)
- 126.38K
- Price to Earnings (P/E)
- 14.1
- Beta (1Y)
- 0.14
- Revenue Growth
- 19.42%
- EPS Growth
- 56.90%
- Country
- TW
- Employees
- 445
- Sector
- General
- Sector Strength
- 55
- Industry
- Leisure
Power Wind Health Industry Incorporated Business Overview & Revenue Model
Company Description
Power Wind Health Industry Inc. operates a network of membership-based fitness clubs and recreational sports facilities throughout Taiwan, offering a range of related athletic services. Its offerings include comprehensive sports training programs. Es...
Power Wind Health Industry Incorporated Financial Statement Overview
Summary
A strong operational turnaround is offset by a highly leveraged balance sheet. Revenue has more than doubled since 2021 to NT$6.07 billion, with gross margin expanding to 31.9% and net margin to 11.0%, while operating cash flow of NT$2.22 billion and free cash flow of NT$1.55 billion (about 2.3x net income) confirm high-quality, cash-backed earnings. The clear weakness is leverage: NT$7.52 billion of debt against only NT$2.36 billion of equity (3.19x debt-to-equity), which flatters the 28.2% ROE and leaves limited buffer if membership demand or pricing softens. Leverage is trending down from its 2023 peak, but heavy depreciation and ongoing club expansion capex keep much of the cash flow committed.
Income Statement
79PositiveBalance Sheet
44NeutralCash Flow
84Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.64B | 6.07B | 5.12B | 4.30B | 3.61B | 2.61B |
| Gross Profit | 2.22B | 1.94B | 1.45B | 1.03B | 829.51M | 328.69M |
| EBITDA | 2.32B | 2.15B | 1.73B | 1.34B | 1.19B | 803.30M |
| Net Income | 843.61M | 666.00M | 370.37M | 112.14M | 71.01M | -142.32M |
Balance Sheet | ||||||
| Total Assets | 12.89B | 11.99B | 10.64B | 10.09B | 9.34B | 8.17B |
| Cash, Cash Equivalents and Short-Term Investments | 2.63B | 1.80B | 1.40B | 1.23B | 1.21B | 1.12B |
| Total Debt | 7.67B | 7.52B | 6.96B | 7.05B | 6.43B | 5.42B |
| Total Liabilities | 10.47B | 9.61B | 8.60B | 8.31B | 7.63B | 6.51B |
| Stockholders Equity | 2.41B | 2.36B | 2.02B | 1.77B | 1.70B | 1.66B |
Cash Flow | ||||||
| Free Cash Flow | 1.88B | 1.55B | 1.32B | 861.26M | 710.65M | 88.11M |
| Operating Cash Flow | 2.55B | 2.22B | 1.94B | 1.47B | 1.19B | 820.14M |
| Investing Cash Flow | -685.42M | -678.11M | -735.86M | -604.72M | -479.98M | -743.13M |
| Financing Cash Flow | -821.17M | -1.23B | -1.12B | -851.11M | -662.93M | 54.95M |
Power Wind Health Industry Incorporated Peers Comparison
Overall Rating
TW:170773Outperform- TW:846268Neutral
TW:843662Neutral
TW:694540Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:1707 | 73Outperform | TWD 11.75B | 11.04 | ― | 7.57% | -5.38% | -12.85% |
| TW:8462 | 68Neutral | TWD 12.09B | 14.08 | ― | 4.84% | 19.42% | 56.90% |
| TW:8436 | 62Neutral | TWD 10.68B | 9.60 | ― | 6.52% | -3.82% | 2.23% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:6945 | 40Underperform | TWD 11.22B | -20.83 | ― | ― | ― | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:8462 | Power Wind Health Industry Incorporated | 150.50 | 0.93 | 0.62% | |
| TW:1707 | Grape King Bio Ltd. | 79.30 | -42.31 | -34.79% | |
| TW:6748 | ACRO Biomedical Co., Ltd. | 168.50 | 107.65 | 176.90% | |
| TW:6945 | AP Biosciences, Inc. | 115.00 | 1.00 | 0.88% | |
| TW:7780 | Daiken Biomedical Co., Ltd. | 14.95 | -1.36 | -8.31% | |
| TW:8436 | TCI Co., Ltd. | 92.20 | -24.45 | -20.96% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026